Albendazole Tablets IP 400 mg
Albendazole
- Dosage Form
- Tablet (chewable)
- Strength
- 400 mg
- HS Code
- 3004.90
- MOQ
- MOQ on request — MDA/tender quantities supported
Target markets: Africa, SE Asia, LatAm
Try: Paracetamol, Amoxicillin, Dolutegravir, HS code, Africa, RCMC
A growing but protectionist corridor. Brazil (ANVISA) and Mexico (COFEPRIS) are semi-regulated markets with substantial paperwork requirements, while Central American and Andean markets such as Guatemala, Peru, Bolivia and the Dominican Republic fall into the more accessible emerging-market tier.
Countries: Brazil, Mexico, Guatemala, Peru, Bolivia, Dominican Republic
Pathway
ANVISA (Brazil), COFEPRIS (Mexico) for Tier 2 markets; national regulators with a CTD-lite dossier for Tier 3 Central American and Andean markets.
Plant Requirement
WHO-GMP + COPP usually accepted; ANVISA and COFEPRIS may conduct their own plant inspection.
Timeline
12–36 months in Brazil/Mexico; 4–18 months in Tier 3 Central/South American markets
Barrier to Entry
Medium to high in Brazil/Mexico; low to medium elsewhere
Central America and the Andean markets are a realistic entry point; Brazil and Mexico are longer-horizon markets once documentation processes are established.
Not typically for a new exporter — ANVISA registration is semi-regulated with 12–36 month timelines and mandatory local representation. Guatemala, Peru, Bolivia and the Dominican Republic are more accessible starting points.
Albendazole
Target markets: Africa, SE Asia, LatAm
Amoxicillin (as trihydrate)
Target markets: Africa, SE Asia, LatAm, CIS
Atorvastatin Calcium
Target markets: Africa, SE Asia, LatAm, CIS
Azithromycin
Target markets: Africa, SE Asia, LatAm
Cetirizine Dihydrochloride
Target markets: Africa, SE Asia, LatAm, Middle East
Single-use disposable syringe with needle
Target markets: Africa, SE Asia, Middle East, LatAm